US market: 2008 priorities.

作者信息

Novelli Thomas

机构信息

Medical Device Manufactures Association, Washington, District of Columbia 20005, USA.

出版信息

Med Device Technol. 2008 May-Jun;19(3):58.

PMID:18557412

Abstract

摘要

相似文献

US market: 2008 priorities.

Med Device Technol. 2008 May-Jun;19(3):58.

Senate subcommittee hears GPOs and critics.

Hosp Mater Manage. 2002 Jun;27(6):1, 14-6.

Branded drug reformulation: the next brand vs. generic antitrust battleground.

Food Drug Law J. 2007;62(1):249-56.

Settlements between brand and generic pharmaceutical companies: a reasonable antitrust analysis of reverse payments.

Fordham Law Rev. 2006 Dec;75(3):1883-912.

Suppliers unhappy with market share turn to courts.

Hosp Mater Manage. 2004 Sep;29(9):2, 14.

Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering.

Seton Hall Law Rev. 2003;33(2):479-510.

Pharmaceutical patent settlements: the antitrust risks.

Food Drug Law J. 2000;55(3):321-41.

Bundling patented drugs and medical services: an antitrust analysis.

Spec Law Dig Health Care Law. 1992 Jan(155):7-39.

Is Noerr-Pennington immunity still a viable defense against antitrust claims arising from Hatch-Waxman litigation?

Food Drug Law J. 2006;61(4):679-700.

Minimizing the antitrust risks of group purchasing.

Hosp Mater Manage Q. 1989 Nov;11(2):77-83.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验